Shanghai Haiyan Pharmaceutical Technology Co., Ltd.

This early-phase trial tests an experimental tablet called YZJ-5053 in people with advanced solid tumors who have no standard treatment options left. The main goals are to find a safe dose and check for side effects. Researchers will also look at how the drug moves through the bo…

This early-stage study tests a new drug called YZJ-4729 tartrate, given as an injection, to see if it is safe and how the body handles it. The trial involves healthy adults aged 18 to 45. Researchers will measure side effects, drug levels in the blood, and how the drug is process…

This phase 3 study tests whether YZJ-1139 tablets help adults with insomnia fall asleep faster and sleep more efficiently. Participants receive either 20 mg, 40 mg, or a placebo daily for two weeks. Sleep is measured using both sleep diaries and overnight lab tests.

This phase 2 trial tests an experimental painkiller called YZJ-4729 in people experiencing moderate to severe pain after orthopedic surgery. Participants receive either YZJ-4729, morphine, or a placebo through an IV, and researchers measure pain relief over 48 hours. The goal is …

This clinical trial tests whether a new drug called YZJ-1139 can help people with insomnia sleep better than the commonly used medication zolpidem. Adults aged 18 to 64 with insomnia disorder take either YZJ-1139 or zolpidem daily for 28 days. Researchers measure sleep quality us…

This study tests a new drug called YZJ-4729 for people experiencing moderate to severe pain after abdominal surgery. Participants are randomly assigned to receive one of several doses of YZJ-4729, a placebo, or the standard painkiller morphine. The goal is to see how well YZJ-472…

This study examines whether ticagrelor, a heart medication, changes how the body absorbs and processes YZJ-1139, an experimental insomnia treatment. Healthy volunteers aged 18 to 45 will take YZJ-1139 alone and then with ticagrelor to compare drug levels and safety. The goal is t…

This study examines whether a new insomnia drug, YZJ-1139, can be safely taken with the antidepressant escitalopram. Healthy adults aged 18 to 45 will receive both drugs and be monitored for side effects, drug levels in the blood, and changes in eye movements, balance, and thinki…

This study examines how the sleep aid YZJ-1139 behaves in people with severe kidney impairment compared to those with normal kidney function. Sixteen adults will receive a single 20 mg dose, and researchers will measure drug levels in the blood and urine, as well as any side effe…